Kathy LaPorte

Kathy LaPorte

Director/Board Member at PRECIPIO, INC.

Net worth: 92 194 $ as of 30/03/2024

62 year
Health Technology
Finance
Health Services

Profile

Kathy D.
LaPorte
was the founder of New Leaf Venture Partners LLC, which was founded in 2005.
She held the title of Partner at the firm.
Ms. LaPorte is also the founder of HealthTech Capital Co. Ms. LaPorte's current job(s) include being a Director at Aesthetic Sciences Corp., Precipio Diagnostics LLC, Bolt Biotherapeutics, Inc., Precipio, Inc., Elysium Therapeutics, Inc., 89bio, Inc., Q32 Bio, Inc. (Massachusetts), D2G Oncology, Inc., and CERo Therapeutics Holdings, Inc. She is also a Director at Q32 Bio, Inc.Ms. LaPorte's former job(s) include being the Chief Executive Officer at Nodality, Inc. from 2015 to 2016.
She was also a Director at Cytyc Prenatal Products Corp., Onyx Pharmaceuticals, Inc., ISTA Pharmaceuticals, Inc., VNUS Medical Technologies, Inc., Transcept Pharmaceuticals, Inc. (Old), eHealth, Inc., Affymax, Inc., Cellgate, Inc., Prometheus Laboratories, Inc., eHealthInsurance Services, Inc., California Institute for Regenerative Medicine, Pearl Therapeutics, Inc., Transcept Pharma, Inc., Phoenix Biotech Acquisition Corp., and First Boston Corp.
She was a General Partner at Sprout Group from 1993 to 2004 and a Principal at Asset Management Co. from 1987 to 1992.
She was also a Partner at New Leaf Venture Partners LLC from 2005 to 2011 and a General Partner at Credit Suisse Securities (USA) LLC in 2005.
Additionally, she served as the President of the Western Association of Venture Capitalists.
Ms. LaPorte's education includes an undergraduate degree from Yale University in 1983 and an MBA from Stanford Graduate School of Business in 1987.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/04/2024 10,071 ( 0.71% ) 67 476 $ 30/03/2024
0.04%
04/04/2024 5,828 ( 0.04% ) 17 892 $ 30/03/2024
0.00%
24/03/2024 302 ( 0.00% ) 5 146 $ 30/03/2024
11/06/2023 1,200 ( 0.00% ) 1 680 $ 30/03/2024
31/01/2024 0 ( -.--% ) - $ 30/03/2024

Kathy LaPorte active positions

CompaniesPositionStart
PRECIPIO, INC. Director/Board Member 08/08/2018
BOLT BIOTHERAPEUTICS, INC. Director/Board Member 30/11/2020
89BIO, INC. Director/Board Member 31/10/2021
Director/Board Member 31/07/2016
Director/Board Member 31/12/2019
Director/Board Member 02/08/2021
Director/Board Member -
Director/Board Member -
All active positions of Kathy LaPorte

Former positions of Kathy LaPorte

CompaniesPositionEnd
California Institute for Regenerative Medicine Director/Board Member 31/08/2017
░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Kathy LaPorte's experience

Training of Kathy LaPorte

Yale University Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kathy LaPorte's experience

Connections

100 +

1st degree connections

32

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
EHEALTH, INC.

Finance

AFFYMAX, INC.

Health Technology

BOLT BIOTHERAPEUTICS, INC.

Health Technology

PRECIPIO, INC.

Health Services

89BIO, INC.

Health Technology

Private companies25
First Boston Corp.

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Finance

Health Technology

Finance

Health Technology

Finance

Finance

Finance

California Institute for Regenerative Medicine

Government

Western Association of Venture Capitalists

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

See company connections